D-0649-2016 Class II Terminated
FDA drug recall D-0649-2016 was initiated by Pfizer Inc. on Jan 11, 2016 and is designated Class II. Reason for recall: FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules. The recall status is terminated (terminated Apr 24, 2017). Affected quantity: 116,400 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 10, 2016
- Initiation Date
- Jan 11, 2016
- Termination Date
- Apr 24, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 116,400 bottles
Product description
Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
Reason for recall
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0649-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.